Targeting brain protein could halt progression of Alzheimer's

A protein that stimulates the brain to wake up could hold the key to preventative Alzheimer's treatments, an animal study suggests.

Alzheimer's: brain cell showing signs of disease (Photo: Science Photo Library)
Alzheimer's: brain cell showing signs of disease (Photo: Science Photo Library)

A mouse-model study conducted by US researchers suggests that targeting orexin, a neurotransmitter that helps rouse the brain from sleep, could help prevent Alzheimer’s disease in patients who have problems sleeping.

Sleep loss is known to contribute to the growth of brain plaques, early signs of Alzheimer’s disease.

They accumulate in the brain ahead of the onset of the more severe symptoms, such as memory loss. Scientists hope that by slowing or stopping this build-up, they can put a halt on the disease.

In the latest study, published in the Journal of Experimental Medicine, researchers bred genetically-modified mice lacking the gene for producing orexin with those predisposed to developing brain plaques.

Brain plaques halved

The offspring slept for longer and developed only half as many brain plaques as their predisposed parents who had the orexin protein, suggesting that higher levels of the neurotransmitter contribute to producing more brain plaques.

When the scientists reversed the experiment, and looked at mice with artificially increased orexin levels, the mice stayed awake longer and developed more Alzheimer's-like plaques.

Lead author Dr David Holtzman said: ‘This indicates we should be looking hard at orexin as a potential target for preventing Alzheimer’s disease.

‘Blocking orexin to increase sleep in patients with sleep abnormalities, or perhaps even to improve sleep efficiency in healthy people, may be a way to reduce the risk of Alzheimer's. This is important to explore further.’

Have you registered with us yet?

Register now to enjoy more articles and free email bulletins

Register

Already registered?

Sign in

Follow Us:

Just published

NHS England to redesign GP appraisal in light of COVID-19 pandemic

NHS England to redesign GP appraisal in light of COVID-19 pandemic

GP appraisals are being redesigned to have a greater focus on wellbeing and reduced...

Primary care to lose millions in funding unless PCNs hit recruitment targets in pandemic

Primary care to lose millions in funding unless PCNs hit recruitment targets in pandemic

Hundreds of millions of pounds could be lost to primary care if primary care networks...

Practices told to prepare for 'major expansion' of flu vaccination as QOF pared back for 2020/21

Practices told to prepare for 'major expansion' of flu vaccination as QOF pared back for 2020/21

GP practices have been told to 'gear up for a major expansion of the winter flu programme'...

NHS England unveils GP contract plans for second phase of COVID-19 response

NHS England unveils GP contract plans for second phase of COVID-19 response

GPs have been told to re-start health checks and other suspended services as NHS...

More than 80% of patients report 'good' overall experience of general practice

More than 80% of patients report 'good' overall experience of general practice

Public satisfaction with GP services remains high, with 82% of patients reporting...

GPs condemn 'deafening silence' from chancellor on COVID support funding

GPs condemn 'deafening silence' from chancellor on COVID support funding

GP leaders have condemned a 'deafening silence' on COVID-19 relief funding for general...